The clinical supply chain is reportedly reaching a significant point with the integration of artificial intelligence. However, it is unclear if this development is directly related to recent events, such as potential disruptions to generic drug prescriptions or changes in device sterilization regulations. The timing and impact of this turning point in the clinical supply chain remain uncertain.